

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.40757563 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.30132981 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.28753565 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.05620940 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.61561712 |
| 6 | vocalization behavior (GO:0071625) | 5.60459931 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.42899619 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.35670050 |
| 9 | glutamate secretion (GO:0014047) | 5.30957980 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.26316177 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.08023690 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.04775747 |
| 13 | presynaptic membrane assembly (GO:0097105) | 4.95880157 |
| 14 | protein localization to synapse (GO:0035418) | 4.84030067 |
| 15 | regulation of synapse structural plasticity (GO:0051823) | 4.78229514 |
| 16 | exploration behavior (GO:0035640) | 4.76618621 |
| 17 | presynaptic membrane organization (GO:0097090) | 4.76105883 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.72769534 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.67905337 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.58087946 |
| 21 | layer formation in cerebral cortex (GO:0021819) | 4.54732611 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.52603498 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.49413272 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 4.49410848 |
| 25 | axon ensheathment in central nervous system (GO:0032291) | 4.43298142 |
| 26 | central nervous system myelination (GO:0022010) | 4.43298142 |
| 27 | neuronal action potential propagation (GO:0019227) | 4.36615564 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.35366090 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 4.28230231 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 4.23106898 |
| 31 | neuron cell-cell adhesion (GO:0007158) | 4.22675095 |
| 32 | gamma-aminobutyric acid transport (GO:0015812) | 4.15183435 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.14358381 |
| 34 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.14136912 |
| 35 | long-term memory (GO:0007616) | 4.11239281 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.07429235 |
| 37 | positive regulation of membrane potential (GO:0045838) | 4.02874192 |
| 38 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.98323368 |
| 39 | cellular potassium ion homeostasis (GO:0030007) | 3.96422772 |
| 40 | positive regulation of synapse maturation (GO:0090129) | 3.86783521 |
| 41 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.79711125 |
| 42 | proline transport (GO:0015824) | 3.77607067 |
| 43 | regulation of postsynaptic membrane potential (GO:0060078) | 3.75682933 |
| 44 | neuromuscular process controlling balance (GO:0050885) | 3.74878456 |
| 45 | sodium ion export (GO:0071436) | 3.70408734 |
| 46 | auditory behavior (GO:0031223) | 3.69949422 |
| 47 | activation of protein kinase A activity (GO:0034199) | 3.69565091 |
| 48 | regulation of synaptic plasticity (GO:0048167) | 3.68254398 |
| 49 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.64171335 |
| 50 | prepulse inhibition (GO:0060134) | 3.63409925 |
| 51 | amino acid import (GO:0043090) | 3.61908457 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.61413822 |
| 53 | neurotransmitter transport (GO:0006836) | 3.58004832 |
| 54 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.55604963 |
| 55 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.51545121 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.48152744 |
| 57 | long-term synaptic potentiation (GO:0060291) | 3.46122854 |
| 58 | dendrite morphogenesis (GO:0048813) | 3.45897692 |
| 59 | transmission of nerve impulse (GO:0019226) | 3.45705366 |
| 60 | response to auditory stimulus (GO:0010996) | 3.44576194 |
| 61 | regulation of synapse maturation (GO:0090128) | 3.43788985 |
| 62 | potassium ion homeostasis (GO:0055075) | 3.40793010 |
| 63 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.40262697 |
| 64 | startle response (GO:0001964) | 3.38418507 |
| 65 | cellular sodium ion homeostasis (GO:0006883) | 3.35965304 |
| 66 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.35947090 |
| 67 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.35558790 |
| 68 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.35359955 |
| 69 | positive regulation of neurotransmitter transport (GO:0051590) | 3.35010272 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 3.34708916 |
| 71 | synaptic vesicle endocytosis (GO:0048488) | 3.28740049 |
| 72 | neuron recognition (GO:0008038) | 3.28001640 |
| 73 | regulation of neurotransmitter transport (GO:0051588) | 3.27038283 |
| 74 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.25499669 |
| 75 | adult walking behavior (GO:0007628) | 3.25300321 |
| 76 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24205597 |
| 77 | postsynaptic membrane organization (GO:0001941) | 3.24109205 |
| 78 | glycine transport (GO:0015816) | 3.23034298 |
| 79 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.22544129 |
| 80 | potassium ion import (GO:0010107) | 3.22177061 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.20451659 |
| 82 | membrane depolarization (GO:0051899) | 3.20370421 |
| 83 | membrane hyperpolarization (GO:0060081) | 3.20186941 |
| 84 | acidic amino acid transport (GO:0015800) | 3.20080654 |
| 85 | regulation of ARF protein signal transduction (GO:0032012) | 3.19259314 |
| 86 | regulation of dendritic spine development (GO:0060998) | 3.19200122 |
| 87 | establishment of mitochondrion localization (GO:0051654) | 3.18367425 |
| 88 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.17328928 |
| 89 | cerebellar granule cell differentiation (GO:0021707) | 3.17039409 |
| 90 | behavioral defense response (GO:0002209) | 3.16881106 |
| 91 | behavioral fear response (GO:0001662) | 3.16881106 |
| 92 | regulation of vesicle fusion (GO:0031338) | 3.15650133 |
| 93 | membrane depolarization during action potential (GO:0086010) | 3.14175167 |
| 94 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.14023565 |
| 95 | response to histamine (GO:0034776) | 3.13709595 |
| 96 | learning (GO:0007612) | 3.13359429 |
| 97 | vesicle transport along microtubule (GO:0047496) | 3.11065411 |
| 98 | cell communication by electrical coupling (GO:0010644) | 3.10651258 |
| 99 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.09280773 |
| 100 | neuromuscular process (GO:0050905) | 3.08394729 |
| 101 | positive regulation of dendritic spine development (GO:0060999) | 3.08331138 |
| 102 | axonal fasciculation (GO:0007413) | 3.08221893 |
| 103 | neuromuscular process controlling posture (GO:0050884) | 3.08113636 |
| 104 | dendritic spine organization (GO:0097061) | 3.07518849 |
| 105 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.07215379 |
| 106 | cell differentiation in hindbrain (GO:0021533) | 3.07060053 |
| 107 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.06009473 |
| 108 | positive regulation of synaptic transmission (GO:0050806) | 3.05345554 |
| 109 | synapse assembly (GO:0007416) | 3.05342167 |
| 110 | * synaptic transmission (GO:0007268) | 3.03983602 |
| 111 | neuronal ion channel clustering (GO:0045161) | 3.03003852 |
| 112 | negative regulation of dendrite development (GO:2000171) | 3.02831571 |
| 113 | serotonin metabolic process (GO:0042428) | 3.02443706 |
| 114 | L-amino acid import (GO:0043092) | 3.01881362 |
| 115 | innervation (GO:0060384) | 3.01115353 |
| 116 | mechanosensory behavior (GO:0007638) | 2.99316089 |
| 117 | regulation of synaptic transmission (GO:0050804) | 2.99292267 |
| 118 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.99243147 |
| 119 | behavioral response to cocaine (GO:0048148) | 2.98119514 |
| 120 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.97951514 |
| 121 | detection of calcium ion (GO:0005513) | 2.97082929 |
| 122 | neuromuscular synaptic transmission (GO:0007274) | 2.96881411 |
| 123 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.96868352 |
| 124 | C4-dicarboxylate transport (GO:0015740) | 2.95188489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.73304739 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.45310690 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10787304 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.04393420 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02007026 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.88032567 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74082315 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71525679 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71525679 |
| 10 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69554738 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60169660 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54562374 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.53780426 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53687447 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44438953 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41694513 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40378162 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.26202640 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.26198452 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.26007143 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.21578480 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19156083 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.17747086 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13012768 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.08134261 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.07449036 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90107967 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87588748 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.82887295 |
| 30 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.71062733 |
| 31 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69840683 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.63963972 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.62123238 |
| 34 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.57482285 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.57098352 |
| 36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.53930083 |
| 37 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41321757 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35269584 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34977572 |
| 40 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.32577103 |
| 41 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32365803 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31996123 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31860441 |
| 44 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30954593 |
| 45 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30950915 |
| 46 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30898287 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.30001786 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26630487 |
| 49 | * AR_19668381_ChIP-Seq_PC3_Human | 1.26384454 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26142476 |
| 51 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25168960 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23000933 |
| 53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22423954 |
| 54 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21715187 |
| 55 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21480812 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19846662 |
| 57 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18643564 |
| 58 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.17343183 |
| 59 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17012206 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16726070 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16658220 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16391497 |
| 63 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.16026892 |
| 64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15535488 |
| 65 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14746272 |
| 66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13771490 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13566665 |
| 68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12839599 |
| 69 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11169658 |
| 70 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10676408 |
| 71 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10548750 |
| 72 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09895343 |
| 73 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09610532 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08502560 |
| 75 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.07883629 |
| 76 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07432980 |
| 77 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06783987 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05648865 |
| 79 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05570768 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04433286 |
| 81 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04220546 |
| 82 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03913818 |
| 83 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.03828047 |
| 84 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03449847 |
| 85 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02112702 |
| 86 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01031811 |
| 87 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00522491 |
| 88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00422972 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00149383 |
| 90 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99348767 |
| 91 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98767310 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98748425 |
| 93 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98390386 |
| 94 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98022048 |
| 95 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97296174 |
| 96 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96833107 |
| 97 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.96175094 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95913883 |
| 99 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.95350475 |
| 100 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95148119 |
| 101 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.93504171 |
| 102 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.93494404 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93478449 |
| 104 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93448833 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93218392 |
| 106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92806407 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92235684 |
| 108 | JUN_21703547_ChIP-Seq_K562_Human | 0.91340859 |
| 109 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90153411 |
| 110 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89534762 |
| 111 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89101778 |
| 112 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88769589 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88675553 |
| 114 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88314935 |
| 115 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86883152 |
| 116 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86806980 |
| 117 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86608087 |
| 118 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.84101773 |
| 119 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84101773 |
| 120 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.82804318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.25474458 |
| 2 | MP0003880_abnormal_central_pattern | 4.43716485 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.40017919 |
| 4 | MP0002822_catalepsy | 3.80387658 |
| 5 | MP0009745_abnormal_behavioral_response | 3.59015510 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.56796260 |
| 7 | * MP0004270_analgesia | 3.41069375 |
| 8 | MP0009046_muscle_twitch | 3.30206194 |
| 9 | MP0002064_seizures | 3.25312102 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.01722286 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.90855772 |
| 12 | MP0001486_abnormal_startle_reflex | 2.74032631 |
| 13 | MP0002272_abnormal_nervous_system | 2.63817533 |
| 14 | * MP0002734_abnormal_mechanical_nocicepti | 2.54652795 |
| 15 | * MP0001968_abnormal_touch/_nociception | 2.50885641 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.19337586 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.18063790 |
| 18 | MP0008569_lethality_at_weaning | 2.15012796 |
| 19 | MP0002736_abnormal_nociception_after | 2.10054548 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.09251863 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.07330190 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.98529474 |
| 23 | MP0001970_abnormal_pain_threshold | 1.95047881 |
| 24 | MP0004811_abnormal_neuron_physiology | 1.90172146 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.89981459 |
| 26 | * MP0002067_abnormal_sensory_capabilities | 1.88710739 |
| 27 | MP0004924_abnormal_behavior | 1.85825479 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.85825479 |
| 29 | MP0003329_amyloid_beta_deposits | 1.83519641 |
| 30 | MP0002184_abnormal_innervation | 1.80622303 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.80389166 |
| 32 | MP0000778_abnormal_nervous_system | 1.78091697 |
| 33 | MP0003879_abnormal_hair_cell | 1.73045965 |
| 34 | MP0004858_abnormal_nervous_system | 1.69284661 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.64726224 |
| 36 | MP0004885_abnormal_endolymph | 1.64612062 |
| 37 | MP0000955_abnormal_spinal_cord | 1.58054263 |
| 38 | MP0001984_abnormal_olfaction | 1.57335161 |
| 39 | MP0003633_abnormal_nervous_system | 1.47746241 |
| 40 | MP0002066_abnormal_motor_capabilities/c | 1.46467122 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.46074578 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.42660994 |
| 43 | MP0003787_abnormal_imprinting | 1.34082095 |
| 44 | MP0001529_abnormal_vocalization | 1.23456141 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.19673152 |
| 46 | * MP0003631_nervous_system_phenotype | 1.15534721 |
| 47 | MP0002152_abnormal_brain_morphology | 1.14182511 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.12254585 |
| 49 | MP0004142_abnormal_muscle_tone | 1.10460847 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.10300704 |
| 51 | MP0008872_abnormal_physiological_respon | 1.09265265 |
| 52 | MP0001905_abnormal_dopamine_level | 1.08411228 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.06590566 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.05091568 |
| 55 | MP0002229_neurodegeneration | 1.01859596 |
| 56 | MP0001188_hyperpigmentation | 1.01488428 |
| 57 | MP0001177_atelectasis | 1.01422184 |
| 58 | MP0003075_altered_response_to | 1.01266196 |
| 59 | MP0008874_decreased_physiological_sensi | 1.00851140 |
| 60 | MP0003123_paternal_imprinting | 0.99828198 |
| 61 | MP0003121_genomic_imprinting | 0.99094167 |
| 62 | MP0002069_abnormal_eating/drinking_beha | 0.95557887 |
| 63 | MP0004147_increased_porphyrin_level | 0.94318060 |
| 64 | MP0003690_abnormal_glial_cell | 0.93738010 |
| 65 | MP0008961_abnormal_basal_metabolism | 0.92670479 |
| 66 | MP0002090_abnormal_vision | 0.88894907 |
| 67 | MP0000920_abnormal_myelination | 0.88864744 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 0.88498701 |
| 69 | MP0004085_abnormal_heartbeat | 0.87262525 |
| 70 | MP0000751_myopathy | 0.86960175 |
| 71 | MP0004742_abnormal_vestibular_system | 0.85711465 |
| 72 | MP0003634_abnormal_glial_cell | 0.83878299 |
| 73 | MP0003283_abnormal_digestive_organ | 0.80097900 |
| 74 | MP0000604_amyloidosis | 0.79842231 |
| 75 | MP0001986_abnormal_taste_sensitivity | 0.79821754 |
| 76 | MP0005499_abnormal_olfactory_system | 0.79393766 |
| 77 | MP0005394_taste/olfaction_phenotype | 0.79393766 |
| 78 | MP0005535_abnormal_body_temperature | 0.78283861 |
| 79 | MP0005409_darkened_coat_color | 0.77700863 |
| 80 | MP0000013_abnormal_adipose_tissue | 0.75942441 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.72998898 |
| 82 | MP0002752_abnormal_somatic_nervous | 0.72292391 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 0.70310145 |
| 84 | MP0003122_maternal_imprinting | 0.69993603 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 0.69777176 |
| 86 | * MP0003632_abnormal_nervous_system | 0.68905729 |
| 87 | MP0004215_abnormal_myocardial_fiber | 0.67923693 |
| 88 | MP0004233_abnormal_muscle_weight | 0.67889745 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 0.67420677 |
| 90 | MP0003137_abnormal_impulse_conducting | 0.66620872 |
| 91 | MP0004510_myositis | 0.64819445 |
| 92 | MP0003172_abnormal_lysosome_physiology | 0.64382501 |
| 93 | MP0010386_abnormal_urinary_bladder | 0.64021090 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.61266224 |
| 95 | MP0010768_mortality/aging | 0.60735419 |
| 96 | MP0004484_altered_response_of | 0.59912217 |
| 97 | MP0001346_abnormal_lacrimal_gland | 0.58369023 |
| 98 | MP0000026_abnormal_inner_ear | 0.57605809 |
| 99 | MP0005187_abnormal_penis_morphology | 0.56313575 |
| 100 | MP0004043_abnormal_pH_regulation | 0.56275216 |
| 101 | MP0001943_abnormal_respiration | 0.56187040 |
| 102 | MP0010769_abnormal_survival | 0.56174455 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.55663010 |
| 104 | MP0000566_synostosis | 0.55405373 |
| 105 | MP0005623_abnormal_meninges_morphology | 0.55151114 |
| 106 | MP0003861_abnormal_nervous_system | 0.55003406 |
| 107 | MP0001664_abnormal_digestion | 0.54621127 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.53706517 |
| 109 | MP0002082_postnatal_lethality | 0.53058272 |
| 110 | MP0010770_preweaning_lethality | 0.53058272 |
| 111 | MP0004130_abnormal_muscle_cell | 0.52469275 |
| 112 | MP0005253_abnormal_eye_physiology | 0.50712476 |
| 113 | MP0003956_abnormal_body_size | 0.49451254 |
| 114 | MP0000639_abnormal_adrenal_gland | 0.47330602 |
| 115 | MP0002234_abnormal_pharynx_morphology | 0.45198293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.50780183 |
| 2 | Myokymia (HP:0002411) | 7.46697547 |
| 3 | Focal seizures (HP:0007359) | 5.74848039 |
| 4 | Visual hallucinations (HP:0002367) | 5.12785219 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.88055294 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.50271516 |
| 7 | Action tremor (HP:0002345) | 4.37241457 |
| 8 | Febrile seizures (HP:0002373) | 4.18376803 |
| 9 | Atonic seizures (HP:0010819) | 4.02372369 |
| 10 | Absence seizures (HP:0002121) | 3.95438398 |
| 11 | Broad-based gait (HP:0002136) | 3.90769843 |
| 12 | Poor eye contact (HP:0000817) | 3.86330973 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.75425752 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.75057148 |
| 15 | Ankle clonus (HP:0011448) | 3.65924264 |
| 16 | Dialeptic seizures (HP:0011146) | 3.61709892 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 3.60249674 |
| 18 | Papilledema (HP:0001085) | 3.52558977 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.49456377 |
| 20 | Impaired social interactions (HP:0000735) | 3.46557692 |
| 21 | Abnormal social behavior (HP:0012433) | 3.46557692 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.43553874 |
| 23 | Mutism (HP:0002300) | 3.41505821 |
| 24 | Depression (HP:0000716) | 3.36734504 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.29950089 |
| 26 | Dysmetria (HP:0001310) | 3.21566293 |
| 27 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.20230034 |
| 28 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.20230034 |
| 29 | Hyperventilation (HP:0002883) | 3.14236646 |
| 30 | Postural instability (HP:0002172) | 3.13094713 |
| 31 | Truncal ataxia (HP:0002078) | 3.12506681 |
| 32 | Genetic anticipation (HP:0003743) | 3.11642238 |
| 33 | Anxiety (HP:0000739) | 3.03362767 |
| 34 | Torticollis (HP:0000473) | 3.02997431 |
| 35 | Impaired smooth pursuit (HP:0007772) | 3.00671298 |
| 36 | Scanning speech (HP:0002168) | 2.97745275 |
| 37 | Abnormal eating behavior (HP:0100738) | 2.91002991 |
| 38 | Intention tremor (HP:0002080) | 2.89279046 |
| 39 | Dysmetric saccades (HP:0000641) | 2.88812698 |
| 40 | Abnormality of the lower motor neuron (HP:0002366) | 2.85655919 |
| 41 | Urinary urgency (HP:0000012) | 2.82272892 |
| 42 | Focal dystonia (HP:0004373) | 2.76554435 |
| 43 | Stereotypic behavior (HP:0000733) | 2.74940986 |
| 44 | Excessive salivation (HP:0003781) | 2.71112437 |
| 45 | Drooling (HP:0002307) | 2.71112437 |
| 46 | Spastic gait (HP:0002064) | 2.68392260 |
| 47 | Abnormality of binocular vision (HP:0011514) | 2.66181599 |
| 48 | Diplopia (HP:0000651) | 2.66181599 |
| 49 | Amblyopia (HP:0000646) | 2.65580638 |
| 50 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.64979159 |
| 51 | Hemiparesis (HP:0001269) | 2.64246904 |
| 52 | Annular pancreas (HP:0001734) | 2.63442906 |
| 53 | Hemiplegia (HP:0002301) | 2.59664803 |
| 54 | Megalencephaly (HP:0001355) | 2.58798153 |
| 55 | Progressive inability to walk (HP:0002505) | 2.54849937 |
| 56 | Bradykinesia (HP:0002067) | 2.49659449 |
| 57 | Craniofacial dystonia (HP:0012179) | 2.47661712 |
| 58 | Neurofibrillary tangles (HP:0002185) | 2.44172672 |
| 59 | Epileptiform EEG discharges (HP:0011182) | 2.44028023 |
| 60 | Impaired vibratory sensation (HP:0002495) | 2.40975216 |
| 61 | Ventricular fibrillation (HP:0001663) | 2.38316574 |
| 62 | Abnormality of the corticospinal tract (HP:0002492) | 2.37965163 |
| 63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.35433573 |
| 64 | Termporal pattern (HP:0011008) | 2.32549506 |
| 65 | Insidious onset (HP:0003587) | 2.32549506 |
| 66 | Cerebral hypomyelination (HP:0006808) | 2.32402042 |
| 67 | Fetal akinesia sequence (HP:0001989) | 2.31265675 |
| 68 | Cerebral inclusion bodies (HP:0100314) | 2.29406274 |
| 69 | Pointed chin (HP:0000307) | 2.28442452 |
| 70 | Amyotrophic lateral sclerosis (HP:0007354) | 2.26652476 |
| 71 | Status epilepticus (HP:0002133) | 2.26461871 |
| 72 | Hypsarrhythmia (HP:0002521) | 2.25314370 |
| 73 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.25059292 |
| 74 | Obstructive sleep apnea (HP:0002870) | 2.24992838 |
| 75 | Absent speech (HP:0001344) | 2.24505366 |
| 76 | Limb dystonia (HP:0002451) | 2.23611313 |
| 77 | Lower limb muscle weakness (HP:0007340) | 2.18626493 |
| 78 | Protruding tongue (HP:0010808) | 2.18196007 |
| 79 | Gait imbalance (HP:0002141) | 2.16468885 |
| 80 | Inappropriate behavior (HP:0000719) | 2.15130127 |
| 81 | Inability to walk (HP:0002540) | 2.13769789 |
| 82 | Peripheral hypomyelination (HP:0007182) | 2.11869246 |
| 83 | Generalized myoclonic seizures (HP:0002123) | 2.10995150 |
| 84 | Sleep apnea (HP:0010535) | 2.08327534 |
| 85 | Clonus (HP:0002169) | 2.06302687 |
| 86 | Spastic tetraplegia (HP:0002510) | 2.06151219 |
| 87 | Resting tremor (HP:0002322) | 2.05957448 |
| 88 | Abnormality of saccadic eye movements (HP:0000570) | 2.05377462 |
| 89 | Lower limb amyotrophy (HP:0007210) | 2.02946189 |
| 90 | Ankyloglossia (HP:0010296) | 2.01314870 |
| 91 | Gait ataxia (HP:0002066) | 1.99738280 |
| 92 | Insomnia (HP:0100785) | 1.99729205 |
| 93 | Incomplete penetrance (HP:0003829) | 1.97531153 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 1.97136433 |
| 95 | Pheochromocytoma (HP:0002666) | 1.95724497 |
| 96 | Bundle branch block (HP:0011710) | 1.95096137 |
| 97 | Abnormal EKG (HP:0003115) | 1.95046214 |
| 98 | Agitation (HP:0000713) | 1.92630388 |
| 99 | Delusions (HP:0000746) | 1.91918520 |
| 100 | Polyphagia (HP:0002591) | 1.90834983 |
| 101 | Blue irides (HP:0000635) | 1.88456971 |
| 102 | Abnormality of the labia minora (HP:0012880) | 1.87393577 |
| 103 | Syncope (HP:0001279) | 1.84174645 |
| 104 | Prolonged QT interval (HP:0001657) | 1.83294712 |
| 105 | Lower limb asymmetry (HP:0100559) | 1.82715370 |
| 106 | Paraplegia (HP:0010550) | 1.81828974 |
| 107 | Rigidity (HP:0002063) | 1.81780854 |
| 108 | Hypoplasia of the corpus callosum (HP:0002079) | 1.81420003 |
| 109 | Increased circulating renin level (HP:0000848) | 1.81184926 |
| 110 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.80582084 |
| 111 | Intellectual disability, profound (HP:0002187) | 1.80436721 |
| 112 | Spastic tetraparesis (HP:0001285) | 1.80406692 |
| 113 | Akinesia (HP:0002304) | 1.78585410 |
| 114 | Apathy (HP:0000741) | 1.76564138 |
| 115 | Abnormality of salivation (HP:0100755) | 1.76545435 |
| 116 | Alacrima (HP:0000522) | 1.75944257 |
| 117 | Spastic paraplegia (HP:0001258) | 1.75726003 |
| 118 | CNS hypomyelination (HP:0003429) | 1.75672214 |
| 119 | Aqueductal stenosis (HP:0002410) | 1.71398529 |
| 120 | Tetraplegia (HP:0002445) | 1.69775178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.59933468 |
| 2 | NTRK3 | 4.31640306 |
| 3 | MAP3K9 | 3.93863117 |
| 4 | MARK1 | 3.82846288 |
| 5 | MAP3K4 | 2.88070973 |
| 6 | DAPK2 | 2.82309302 |
| 7 | MINK1 | 2.69321494 |
| 8 | MAP2K7 | 2.34647981 |
| 9 | PAK6 | 2.31838138 |
| 10 | CAMKK1 | 2.24284949 |
| 11 | NTRK2 | 2.21764673 |
| 12 | PRKD3 | 2.21607935 |
| 13 | KSR2 | 2.15205017 |
| 14 | NTRK1 | 1.77891382 |
| 15 | MAP2K4 | 1.74665611 |
| 16 | DAPK1 | 1.67372812 |
| 17 | TNIK | 1.63415647 |
| 18 | KSR1 | 1.63157006 |
| 19 | CDK5 | 1.61215235 |
| 20 | RIPK4 | 1.57372095 |
| 21 | CAMKK2 | 1.46302848 |
| 22 | PRPF4B | 1.43519764 |
| 23 | STK38 | 1.40810923 |
| 24 | MAP3K12 | 1.37078062 |
| 25 | CDK19 | 1.36466752 |
| 26 | CASK | 1.36163064 |
| 27 | TAOK1 | 1.34337703 |
| 28 | SIK2 | 1.30749181 |
| 29 | MAPK13 | 1.29587023 |
| 30 | MAP3K2 | 1.28968611 |
| 31 | FRK | 1.28917047 |
| 32 | TYRO3 | 1.21826323 |
| 33 | PRKCG | 1.19277428 |
| 34 | PLK2 | 1.16600439 |
| 35 | FES | 1.15025197 |
| 36 | PHKG1 | 1.14619810 |
| 37 | PHKG2 | 1.14619810 |
| 38 | GRK5 | 1.08496585 |
| 39 | WNK3 | 1.00300779 |
| 40 | STK11 | 0.99816015 |
| 41 | MAP3K13 | 0.99356366 |
| 42 | CAMK1 | 0.99293131 |
| 43 | UHMK1 | 0.97532094 |
| 44 | LATS2 | 0.96266747 |
| 45 | SGK494 | 0.96072073 |
| 46 | SGK223 | 0.96072073 |
| 47 | ARAF | 0.95389341 |
| 48 | CDK18 | 0.94571687 |
| 49 | CDK15 | 0.93424883 |
| 50 | PRKCH | 0.92824380 |
| 51 | RET | 0.88867529 |
| 52 | CDK14 | 0.88432131 |
| 53 | CAMK2A | 0.88104247 |
| 54 | MARK2 | 0.87316465 |
| 55 | RIPK1 | 0.86275121 |
| 56 | ALK | 0.85706845 |
| 57 | SGK2 | 0.84948154 |
| 58 | CDK11A | 0.81321710 |
| 59 | SGK3 | 0.81239704 |
| 60 | PINK1 | 0.79947930 |
| 61 | RAF1 | 0.78988712 |
| 62 | PNCK | 0.76649223 |
| 63 | PDK1 | 0.74751177 |
| 64 | SGK1 | 0.74185359 |
| 65 | CAMK2B | 0.72880190 |
| 66 | CSNK1G2 | 0.72791158 |
| 67 | BCR | 0.69873200 |
| 68 | CSNK1A1L | 0.69403650 |
| 69 | PAK3 | 0.68316835 |
| 70 | STK39 | 0.67508689 |
| 71 | OXSR1 | 0.67166123 |
| 72 | PDPK1 | 0.66286104 |
| 73 | DYRK2 | 0.65424705 |
| 74 | LMTK2 | 0.65381821 |
| 75 | AKT3 | 0.64120611 |
| 76 | NEK1 | 0.63376065 |
| 77 | CSNK1G3 | 0.62938588 |
| 78 | DYRK1A | 0.62591473 |
| 79 | CCNB1 | 0.55991750 |
| 80 | PRKCZ | 0.55723597 |
| 81 | PTK2B | 0.55487511 |
| 82 | SCYL2 | 0.55281259 |
| 83 | CSNK1G1 | 0.54271099 |
| 84 | RPS6KA3 | 0.54074230 |
| 85 | BMPR2 | 0.52342423 |
| 86 | MAP3K1 | 0.50902422 |
| 87 | CAMK4 | 0.50428726 |
| 88 | NEK6 | 0.50162221 |
| 89 | CSNK1D | 0.47950083 |
| 90 | WNK1 | 0.47590493 |
| 91 | PRKG1 | 0.47580395 |
| 92 | CDC42BPA | 0.46238987 |
| 93 | CAMK1G | 0.45997296 |
| 94 | MAP3K7 | 0.45000490 |
| 95 | * FYN | 0.43730941 |
| 96 | MAPK10 | 0.43554597 |
| 97 | TNK2 | 0.43257939 |
| 98 | ROCK2 | 0.42349962 |
| 99 | BRSK1 | 0.41771225 |
| 100 | PRKCE | 0.41645430 |
| 101 | DMPK | 0.40718899 |
| 102 | DAPK3 | 0.40636562 |
| 103 | CSNK1A1 | 0.39632771 |
| 104 | PRKACA | 0.39434465 |
| 105 | ERBB3 | 0.38925535 |
| 106 | MAPK12 | 0.38763613 |
| 107 | CSNK1E | 0.37708932 |
| 108 | CAMK2G | 0.37604020 |
| 109 | PRKCA | 0.37229616 |
| 110 | CAMK2D | 0.36348664 |
| 111 | FGFR2 | 0.35297348 |
| 112 | MAP2K1 | 0.34905876 |
| 113 | MAP3K6 | 0.34599884 |
| 114 | MAP4K2 | 0.34057677 |
| 115 | PRKCB | 0.33776424 |
| 116 | RPS6KA2 | 0.33248729 |
| 117 | GSK3B | 0.32464927 |
| 118 | TRIM28 | 0.31958097 |
| 119 | PKN1 | 0.30978257 |
| 120 | LIMK1 | 0.30536995 |
| 121 | ERBB2 | 0.29629889 |
| 122 | MAPK8 | 0.28676781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.48393618 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.11385078 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.96354998 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79033321 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.70832531 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.68437177 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.65757947 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.60800029 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.57485167 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43893403 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.20260570 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.18832084 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.15619642 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.02627624 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.95594170 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.93859600 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.91004124 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.71311298 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.70876700 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.70814686 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70682900 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.69887366 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.55922484 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.54573032 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54418526 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45442030 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42976007 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.39945347 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.39881833 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31517375 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31422510 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31314740 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.25913583 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.20529334 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18489871 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18161105 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16777486 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.08967442 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07767640 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.07144879 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06877823 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 1.06444875 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.00722067 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97891466 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92870690 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90983891 |
| 47 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89670308 |
| 48 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86161286 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85011293 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82661413 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82133819 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79804437 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78662776 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77634908 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74526167 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74117656 |
| 57 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72370271 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71496410 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.70847978 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70511767 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67944227 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67816517 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66365044 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65708203 |
| 65 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62658390 |
| 66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61298862 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60630351 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60479107 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59268494 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57499356 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56838995 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55919265 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55602769 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.55224088 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54626662 |
| 76 | Alcoholism_Homo sapiens_hsa05034 | 0.54621944 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.54531676 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54514813 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52772918 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52119812 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51440352 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51208486 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49452485 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47585742 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45984667 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45413859 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45239319 |
| 88 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44538434 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44309167 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43166555 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43046328 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42946888 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42531605 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41923290 |
| 95 | Tight junction_Homo sapiens_hsa04530 | 0.40180719 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39589231 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38128138 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.35670344 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35342501 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.34648220 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33333198 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33029351 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32934143 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31571417 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31567018 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30759079 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.30715143 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30573370 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30026758 |
| 110 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29905520 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29882254 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.28651150 |
| 113 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 0.27806306 |
| 114 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27772477 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26767552 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25400919 |

